Lilly’s stock rallies as sales of GLP-1 drugs nearly double
Short excerpt below. Click through to read at the original source.
Sales of Mounjaro and Zepbound both beat expectations
Short excerpt below. Click through to read at the original source.
Sales of Mounjaro and Zepbound both beat expectations